Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Immunome to become Philadelphia region's sixth life sciences IPO of 2020
2 Immunome Announces Pricing of Upsized Initial Public Offering
3 Immunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering
4 Exton-based Immunome goes public in upsized $39M IPO
5 Immunome sets IPO terms
6 Immunome Aims For $30 Million U.S. IPO
7 How to Buy the Immunome Stock IPO
8 Preclinical oncology biotech Immunome prices upsized IPO at $12 midpoint
9 When Is Immunome IPO Date?
10 Form 3 Immunome Inc. For: Oct 01 Filed by: Lefenfeld Michael
11 Immunome's $44.9 Initial Public Offering – Global Legal Chronicle
12 Immunome sets IPO terms, to raise up to $32.5 million
13 Immunome to get up to $13.3M in government funding for potential Covid-19 drug
14 Preclinical oncology biotech Immunome files for a $30 million IPO
15 Immunome Announces Creation of COVID-19 Advisory Board
16 Tesla, Amazon.com, Uber, Twilio: What to Watch When the Stock Market Opens Today
17 Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
18 Exton's Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
19 Kronos, the Latest Biotech IPO, Soars 58%
20 12 Healthcare Stocks Moving In Monday's Intraday Session
21 Team develops online atlas of human immunome for precision medicine
22 US IPO Weekly Recap: IPOs, SPACs, and direct listings, oh my!
23 IPO Outlook For The Week: Asana, Palantir Lead Busy Week Of Debuts
24 Simpson Thacher Reps Academy For Undersized $203M IPO
25 pH Pharma and Immunome Enter into Collaboration and License Agreement to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates in Oncology
26 US IPO Week Ahead: Palantir and Asana direct-list in 11 IPO week with tech, sports, and avocados
27 Stocks To Watch: Alibaba, PepsiCo, Wayfair And Palantir
28 Financings for Oct. 2, 2020 | 2020-10-02
29 MyoKardia, Eidos Therapeutics leads healthcare gainers, Xtant Medical Holdings, Curis among major losers
30 Immunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer
31 The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
32 Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
33 Ph Pharma and Immunome to collaborate in antibody-drug conjugates
34 Immunome Appoints Michael J. Morin, PhD, As President And Chief Scientific Officer
35 Immunome Raises $12.2 Million in Additional Series A Financing
36 /R E M I N D E R -- Media Advisory
37 New Stocks to Watch at Investor Ideas: Biotech (NASDAQ: $AZYO), Sports (NASDAQ: $ASO), Cleantech (NASDAQ: $ARRY), CBD (NASDAQ: $JUPW)
38 MIT spinout bumps up Series A to $12M+ for novel I/O discovery
39 US IPO Week Ahead: Chinese fintech, pool supplies, and auto insurance lead a diverse 13 IPO weeK
40 Bio Roundup: MESO's Miss, Pfizer's Cancer Bet, Vaccine Promise & More
41 Chester County immunotherapy company names new CEO
42 Dyno sparks a $1.8B deal with Roche to develop CNS therapies
43 Financings for Oct. 14, 2020 | 2020-10-14
44 Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More
45 A wave of mortgage lenders tests the IPO waters
46 Guiding light: Main Line startup taps Lankenau Institute’s glow tech to make antibodies
47 Why I'm optimistic about Philly tech, and why you should be, too: Notes from a former investor
48 US IPO Week Ahead: McAfee returns to the public market in a 5 IPO week
49 Immunome Appoints Purnanand Sarma as President and CEO
50 Last Week's Notable Insider Buys: Element Solutions, Selecta Biosciences And More
51 U.S. IPO Week Ahead: Palantir And Asana Direct-List In 9-IPO Week With Tech, Sports, And Avocados
52 Movers & Shakers, Sept. 18 | BioSpace
53 IPO Calendar: Sept. 28
54 Philadelphia immunotherapy company raises $10.2M
55 Map of immune system may point way to Covid-19 vaccine
56 India needs to export 6 million T sugar as output rebounds: trade body
57 Human Immunomics Initiative Launches in Midst of COVID-19 Pandemic
58 ECB's Knot: interest rates likely to stay low for years
59 Sengenics Announces New Research Collaboration with GSK Focusing on Immunology
60 Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors
61 Wells Fargo profit falls as pandemic hits growth
62 Machine Learning Approach Could Accelerate COVID-19 Drug Discovery
63 J.C. Penney Is in Talks for Bankruptcy Financing. Other Retailers Are Teetering.
64 Financings for Sept. 10, 2020 | 2020-09-10
65 Philadelphia biotech firm battling Covid-19 gets $1M from federal health agency
66 Kindness in Real Life: Local foundation hands out $400000 for research
67 Imagining an immune-driven future
68 Korro banks $91.5M for RNA editing push
69 Appointments and advancements for Sept. 16, 2020 | 2020-09-16
70 Human Immunomics Initiative will decode immune system, speed new vaccines
71 U.S. IPO Weekly Recap: IPO Launches And Filings Abound In The Post-Labor Day Frenzy
72 Grand Challenge: Mapping the Human Immune System
73 EXIMIOUS: how does the environment affect our health? | News
74 Sengenics' Immunome Protein Array Platform Has Five New Applications
75 US IPO Weekly Recap: IPO launches and filings abound in the post-Labor Day frenzy
76 Revealing human antibody secrets: Pushing forward the frontier of vaccine science
77 Hankin's Eagleview continues to attract life science companies
78 Vanderbilt University, Human Vaccines Project partner to decode human immune system
79 Iron Hill announces next location, completing '20 by 20' goal
80 ONCR Stock Price | Oncorus Inc. Stock Quote (US: Nasdaq)
81 City Council extends disaster declaration to October
82 Zafgen : SEC Filing (PREM14A)
83 Effect of increased relative stiffness of the lumbar spine on hamstring muscle stretching in individuals with a history of low back pain suspected to have a clinical lumbar instability: A randomized crossover design.
84 Philadelphia Pharmaceuticals News
85 Life Sciences Pennsylvania names annual award winners, including its Deal of the Year
86 Putting the Pieces Together to Battle Anti-microbial Resistance | AACC.org
87 Orascom Construction's $25 Million Loan Financing – Global Legal Chronicle
88 Exton medical device company advancing a way to help Covid-19 patients learn to breathe again
89 Angelo Gordon buys Exton building for $47M
90 Philadelphia real estate veterans launch new firm
91 Keeping score with immunotherapy response
92 The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
93 Veltek to expand by 115,000 square feet in Exton
94 Inside Bentley Systems' ‘very unusual’ $235M IPO
95 Philadelphia-area life sciences companies expect to reel in more than $425M in a seven-day stretch
96 Vaxess Technologies Closes Final Tranche of $8.2M Series A Funding
97 Charter school pays $15.3M for former Ricoh HQ in Malvern
98 IPO Calendar | May 18
99 TiE Boston Recognizes Entrepreneurs at 2019 Gala: Lifetime Achievement Award for Indian American edX CEO Anant Agarwal
100 Exton retail center’s plea for relief on $37M loan rejected by lender